Alkylating Drug [EPC]

Alkylating Drug [EPC] was reported 243979 times

These side effects are most commonly reported by patients taking drugs of the Alkylating Drug [EPC] class:

# Drug class Count
0 OFF LABEL USE 22823
1 FEBRILE NEUTROPENIA 18970
2 NEUTROPENIA 14289
3 DRUG INEFFECTIVE 14044
4 PYREXIA 12159
5 DISEASE PROGRESSION 11684
6 THROMBOCYTOPENIA 10306
7 PRODUCT USE IN UNAPPROVED INDICATION 9754
8 NAUSEA 9357
9 ANAEMIA 8594
10 DEATH 8486
11 PNEUMONIA 8384
12 DIARRHOEA 7731
13 SEPSIS 7492
14 VOMITING 7260
15 FATIGUE 6371
16 INFECTION 6245
17 PANCYTOPENIA 6116
18 MUCOSAL INFLAMMATION 5488
19 WHITE BLOOD CELL COUNT DECREASED 5312
20 MYELOSUPPRESSION 5266
21 DYSPNOEA 4972
22 MALIGNANT NEOPLASM PROGRESSION 4940
23 PLATELET COUNT DECREASED 4599
24 ASTHENIA 4507
25 NEUROPATHY PERIPHERAL 4206
26 LEUKOPENIA 4128
27 CYTOKINE RELEASE SYNDROME 4063
28 RESPIRATORY FAILURE 3974
29 SEPTIC SHOCK 3948
30 ACUTE KIDNEY INJURY 3830
31 NEUTROPHIL COUNT DECREASED 3790
32 HYPOTENSION 3606
33 HEADACHE 3404
34 CONDITION AGGRAVATED 3314
35 ABDOMINAL PAIN 3160
36 DECREASED APPETITE 3036
37 CYTOMEGALOVIRUS INFECTION 2980
38 BONE MARROW FAILURE 2954
39 RASH 2951
40 ACUTE MYELOID LEUKAEMIA 2921
41 MYELODYSPLASTIC SYNDROME 2907
42 TOXICITY TO VARIOUS AGENTS 2875
43 COVID-19 2845
44 PAIN 2817
45 RENAL FAILURE 2718
46 PLASMA CELL MYELOMA 2630
47 HAEMOGLOBIN DECREASED 2586
48 COUGH 2577
49 CONSTIPATION 2561
50 CARDIAC FAILURE 2489
51 ALOPECIA 2475
52 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2457
53 PULMONARY EMBOLISM 2445
54 PLEURAL EFFUSION 2431
55 HYPERTENSION 2403
56 NEOPLASM PROGRESSION 2350
57 DISEASE RECURRENCE 2289
58 STOMATITIS 2265
59 CYTOPENIA 2221
60 HAEMATOTOXICITY 2213
61 GENERAL PHYSICAL HEALTH DETERIORATION 2211
62 PRODUCT USE ISSUE 2209
63 INTERSTITIAL LUNG DISEASE 2187
64 ATRIAL FIBRILLATION 2117
65 WEIGHT DECREASED 2097
66 ACUTE GRAFT VERSUS HOST DISEASE 2074
67 MALAISE 2062
68 ALANINE AMINOTRANSFERASE INCREASED 2045
69 THERAPY PARTIAL RESPONDER 2039
70 INTENTIONAL PRODUCT USE ISSUE 2008
71 DEHYDRATION 1983
72 GRAFT VERSUS HOST DISEASE 1968
73 URINARY TRACT INFECTION 1939
74 VENOOCCLUSIVE LIVER DISEASE 1939
75 DIZZINESS 1936
76 DIFFUSE LARGE B-CELL LYMPHOMA 1899
77 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1883
78 CONFUSIONAL STATE 1864
79 CHILLS 1861
80 NEUROTOXICITY 1856
81 LYMPHOPENIA 1849
82 THERAPY NON-RESPONDER 1828
83 RENAL IMPAIRMENT 1819
84 SEIZURE 1811
85 CYTOMEGALOVIRUS INFECTION REACTIVATION 1768
86 ARTHRALGIA 1729
87 DEEP VEIN THROMBOSIS 1727
88 HYPOKALAEMIA 1723
89 TREATMENT FAILURE 1697
90 TACHYCARDIA 1671
91 ASPARTATE AMINOTRANSFERASE INCREASED 1661
92 DRUG INTERACTION 1641
93 ENCEPHALOPATHY 1626
94 SECOND PRIMARY MALIGNANCY 1623
95 BACK PAIN 1591
96 PNEUMONITIS 1575
97 NEUTROPENIC SEPSIS 1573
98 HYPOGAMMAGLOBULINAEMIA 1562
99 HYPOXIA 1521
100 CARDIOTOXICITY 1518
101 TUMOUR LYSIS SYNDROME 1499
102 GASTROINTESTINAL DISORDER 1484
103 PNEUMOCYSTIS JIROVECII PNEUMONIA 1472
104 CHEST PAIN 1471
105 HEPATIC FUNCTION ABNORMAL 1471
106 HYPONATRAEMIA 1467
107 PRURITUS 1465
108 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1433
109 CYSTITIS HAEMORRHAGIC 1426
110 AGRANULOCYTOSIS 1422
111 HERPES ZOSTER 1415
112 CHRONIC GRAFT VERSUS HOST DISEASE 1407
113 LYMPHADENOPATHY 1403
114 ERYTHEMA 1378
115 FALL 1376
116 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1374
117 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1373
118 DRUG INTOLERANCE 1373
119 OEDEMA PERIPHERAL 1366
120 HEPATOTOXICITY 1359
121 STAPHYLOCOCCAL INFECTION 1345
122 PAIN IN EXTREMITY 1337
123 THROMBOTIC MICROANGIOPATHY 1323
124 ASPERGILLUS INFECTION 1310
125 BACTERAEMIA 1305
126 ACUTE RESPIRATORY DISTRESS SYNDROME 1301
127 BRONCHOPULMONARY ASPERGILLOSIS 1301
128 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1292
129 COLITIS 1278
130 HEPATIC FAILURE 1272
131 HAEMORRHAGE 1269
132 BLOOD LACTATE DEHYDROGENASE INCREASED 1267
133 BLOOD CREATININE INCREASED 1265
134 LYMPHOCYTE COUNT DECREASED 1260
135 GASTROINTESTINAL HAEMORRHAGE 1255
136 DYSPHAGIA 1252
137 DRUG RESISTANCE 1224
138 ASCITES 1219
139 MUSCULAR WEAKNESS 1216
140 BACTERIAL INFECTION 1189
141 C-REACTIVE PROTEIN INCREASED 1164
142 FEBRILE BONE MARROW APLASIA 1143
143 MYALGIA 1142
144 EJECTION FRACTION DECREASED 1138
145 PARAESTHESIA 1132
146 INFUSION RELATED REACTION 1128
147 HYPERSENSITIVITY 1116
148 EPSTEIN-BARR VIRUS INFECTION 1114
149 FUNGAL INFECTION 1114
150 SYNCOPE 1111
151 CLOSTRIDIUM DIFFICILE COLITIS 1109
152 CARDIAC ARREST 1104
153 BONE PAIN 1101
154 BK VIRUS INFECTION 1090
155 VENOOCCLUSIVE DISEASE 1084
156 CELLULITIS 1083
157 BLOOD BILIRUBIN INCREASED 1067
158 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1066
159 RESPIRATORY DISTRESS 1050
160 HYPERGLYCAEMIA 1023
161 CARDIOMYOPATHY 1022
162 CYTOMEGALOVIRUS VIRAEMIA 1022
163 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 1004
164 HYPOAESTHESIA 976
165 ADENOVIRUS INFECTION 970
166 LUNG DISORDER 958
167 EPISTAXIS 949
168 POLYNEUROPATHY 943
169 SOMNOLENCE 935
170 ABDOMINAL PAIN UPPER 932
171 NEPHROPATHY TOXIC 932
172 HEPATITIS B 930
173 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 923
174 TRANSAMINASES INCREASED 919
175 HAEMATURIA 918
176 PERICARDIAL EFFUSION 916
177 OEDEMA 914
178 PULMONARY OEDEMA 908
179 CONVULSION 904
180 CANDIDA INFECTION 902
181 ANXIETY 900
182 TREMOR 887
183 MATERNAL EXPOSURE DURING PREGNANCY 878
184 CARDIAC FAILURE CONGESTIVE 876
185 LYMPHOMA 875
186 HEPATITIS B REACTIVATION 873
187 METASTASES TO LIVER 871
188 MULTI-ORGAN FAILURE 869
189 INSOMNIA 867
190 THROMBOSIS 867
191 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 866
192 GRAFT VERSUS HOST DISEASE IN SKIN 834
193 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 832
194 GAIT DISTURBANCE 831
195 WEIGHT INCREASED 828
196 DRUG-INDUCED LIVER INJURY 825
197 THERAPEUTIC RESPONSE DECREASED 812
198 OSTEONECROSIS 806
199 FOETAL EXPOSURE DURING PREGNANCY 804
200 UPPER RESPIRATORY TRACT INFECTION 792
201 APLASTIC ANAEMIA 789
202 RENAL FAILURE ACUTE 789
203 RESPIRATORY TRACT INFECTION 784
204 PSEUDOMONAS INFECTION 780
205 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 778
206 MENTAL STATUS CHANGES 776
207 DRUG HYPERSENSITIVITY 774
208 METASTASES TO BONE 772
209 VIRAL INFECTION 770
210 HEPATIC ENZYME INCREASED 758
211 CEREBROVASCULAR ACCIDENT 757
212 CLOSTRIDIUM DIFFICILE INFECTION 739
213 CHEST DISCOMFORT 736
214 DEPRESSION 731
215 LIVER DISORDER 731
216 ABDOMINAL DISTENSION 726
217 DEVICE RELATED INFECTION 722
218 HUMAN HERPESVIRUS 6 INFECTION 720
219 PULMONARY TOXICITY 717
220 LOSS OF CONSCIOUSNESS 714
221 NERVOUS SYSTEM DISORDER 711
222 PREMATURE BABY 710
223 INFLUENZA 704
224 HYPERBILIRUBINAEMIA 696
225 DISSEMINATED INTRAVASCULAR COAGULATION 693
226 METASTASES TO LUNG 690
227 PERIPHERAL SENSORY NEUROPATHY 689
228 SINUSITIS 689
229 BRAIN OEDEMA 687
230 APHASIA 684
231 CEREBRAL HAEMORRHAGE 684
232 MYOCARDIAL INFARCTION 682
233 ACUTE RESPIRATORY FAILURE 676
234 HERPES SIMPLEX 668
235 LEFT VENTRICULAR DYSFUNCTION 665
236 ENTEROCOCCAL INFECTION 660
237 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 659
238 KLEBSIELLA INFECTION 658
239 COVID-19 PNEUMONIA 655
240 HAEMATOCRIT DECREASED 654
241 OROPHARYNGEAL PAIN 654
242 GAMMA-GLUTAMYLTRANSFERASE INCREASED 638
243 PROTEINURIA 638
244 LUNG INFILTRATION 637
245 WHITE BLOOD CELL COUNT INCREASED 633
246 NEOPLASM MALIGNANT 632
247 ACUTE HEPATIC FAILURE 626
248 LUNG INFECTION 625
249 COGNITIVE DISORDER 623
250 HEPATITIS 620
251 LOWER RESPIRATORY TRACT INFECTION 620
252 NO ADVERSE EVENT 618
253 OXYGEN SATURATION DECREASED 612
254 CARDIAC DISORDER 608
255 HYPOALBUMINAEMIA 605
256 LIVER INJURY 605
257 METASTASES TO CENTRAL NERVOUS SYSTEM 604
258 ARRHYTHMIA 595
259 HYPOCALCAEMIA 591
260 LETHARGY 589
261 PANCREATITIS 589
262 ESCHERICHIA INFECTION 584
263 URTICARIA 574
264 DEPRESSED LEVEL OF CONSCIOUSNESS 572
265 HYPOTHYROIDISM 572
266 BLOOD ALKALINE PHOSPHATASE INCREASED 571
267 STAPHYLOCOCCAL SEPSIS 567
268 INFLAMMATION 565
269 CHOLESTASIS 563
270 ADVERSE EVENT 562
271 GASTROINTESTINAL TOXICITY 562
272 STAPHYLOCOCCAL BACTERAEMIA 553
273 HEMIPARESIS 552
274 DIABETES MELLITUS 551
275 ABDOMINAL DISCOMFORT 550
276 PNEUMONIA FUNGAL 549
277 PRODUCTIVE COUGH 547
278 MUSCLE SPASMS 545
279 HOSPITALISATION 544
280 ILL-DEFINED DISORDER 544
281 ANAPHYLACTIC REACTION 538
282 SKIN LESION 536
283 PNEUMOTHORAX 531
284 BLOOD PRESSURE DECREASED 529
285 BREAST CANCER 529
286 HYPERHIDROSIS 526
287 BACTERIAL SEPSIS 525
288 COAGULOPATHY 524
289 CYTOMEGALOVIRUS CHORIORETINITIS 520
290 BRADYCARDIA 519
291 HYPOPHAGIA 518
292 NEOPLASM RECURRENCE 518
293 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 513
294 LEUKOCYTOSIS 513
295 PULMONARY HAEMORRHAGE 507
296 NASOPHARYNGITIS 505
297 TRANSPLANT FAILURE 505
298 BLOOD PRESSURE INCREASED 503
299 VISION BLURRED 501
300 HAEMORRHAGE INTRACRANIAL 500
301 PULMONARY HYPERTENSION 494
302 PERIPHERAL SWELLING 492
303 MEMORY IMPAIRMENT 491
304 PNEUMONIA BACTERIAL 489
305 METASTASIS 488
306 SPLENOMEGALY 486
307 HEART RATE INCREASED 484
308 DYSPNOEA EXERTIONAL 483
309 PALPITATIONS 481
310 PULMONARY FIBROSIS 476
311 EXPOSURE DURING PREGNANCY 469
312 INTESTINAL PERFORATION 468
313 COMA 467
314 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 466
315 ATELECTASIS 462
316 DELIRIUM 462
317 SKIN EXFOLIATION 462
318 CHRONIC KIDNEY DISEASE 460
319 RESPIRATORY DISORDER 460
320 DYSPEPSIA 459
321 ENCEPHALITIS 459
322 HYPERKALAEMIA 459
323 GENERALISED OEDEMA 457
324 SINUS TACHYCARDIA 457
325 PNEUMONIA CYTOMEGALOVIRAL 456
326 BREAST CANCER METASTATIC 455
327 NEUTROPENIC COLITIS 455
328 STEM CELL TRANSPLANT 455
329 RED BLOOD CELL COUNT DECREASED 454
330 DISORIENTATION 453
331 DRUG TOXICITY 452
332 RASH MACULO-PAPULAR 451
333 AGITATION 450
334 ILEUS 449
335 MOUTH ULCERATION 448
336 EPILEPSY 447
337 ORAL CANDIDIASIS 446
338 DYSARTHRIA 443
339 VISUAL IMPAIRMENT 443
340 BRONCHITIS 442
341 SKIN TOXICITY 441
342 CYSTITIS 440
343 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 440
344 JAUNDICE 440
345 RHINOVIRUS INFECTION 438
346 PSYCHOLOGICAL TRAUMA 437
347 APLASIA 434
348 HODGKIN^S DISEASE 432
349 PULMONARY ALVEOLAR HAEMORRHAGE 432
350 ACUTE MYOCARDIAL INFARCTION 431
351 EMBOLISM 430
352 LEUKOENCEPHALOPATHY 430
353 SHOCK 430
354 ACUTE LYMPHOCYTIC LEUKAEMIA 428
355 TACHYPNOEA 428
356 PANCREATITIS ACUTE 427
357 PNEUMOCYSTIS JIROVECI PNEUMONIA 425
358 CARDIO-RESPIRATORY ARREST 424
359 DYSURIA 424
360 BODY TEMPERATURE INCREASED 423
361 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 423
362 BLISTER 422
363 HEPATIC CYTOLYSIS 421
364 HYPERTRANSAMINASAEMIA 418
365 HYPOPHOSPHATAEMIA 417
366 OESOPHAGITIS 417
367 ELECTROLYTE IMBALANCE 412
368 BLOOD GLUCOSE INCREASED 411
369 SYSTEMIC CANDIDA 411
370 FEELING ABNORMAL 407
371 PNEUMONIA ASPIRATION 407
372 ADRENAL INSUFFICIENCY 406
373 RENAL DISORDER 406
374 VIRAL HAEMORRHAGIC CYSTITIS 406
375 IMMUNOSUPPRESSION 403
376 METASTASES TO LYMPH NODES 403
377 PSEUDOMONAL SEPSIS 401
378 OVERDOSE 400
379 CEREBRAL INFARCTION 398
380 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 396
381 RHINORRHOEA 396
382 BASAL CELL CARCINOMA 394
383 MYOCARDITIS 394
384 ESCHERICHIA SEPSIS 392
385 BLINDNESS 391
386 HYPOMAGNESAEMIA 391
387 LIVER FUNCTION TEST ABNORMAL 390
388 OSTEONECROSIS OF JAW 390
389 JC VIRUS INFECTION 389
390 HAEMOPTYSIS 385
391 METABOLIC ACIDOSIS 385
392 DEAFNESS 383
393 TUBULOINTERSTITIAL NEPHRITIS 383
394 NEOPLASM 381
395 CATARACT 380
396 OSTEOPOROSIS 380
397 ACUTE MYELOID LEUKAEMIA RECURRENT 379
398 HAIR COLOUR CHANGES 379
399 ENTERITIS 376
400 HEPATIC STEATOSIS 375
401 INTESTINAL OBSTRUCTION 374
402 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 373
403 RASH ERYTHEMATOUS 373
404 ORGANISING PNEUMONIA 369
405 MUCORMYCOSIS 368
406 SPEECH DISORDER 368
407 CARDIOGENIC SHOCK 367
408 HAIR TEXTURE ABNORMAL 367
409 SWELLING 367
410 CHRONIC LYMPHOCYTIC LEUKAEMIA 366
411 END STAGE RENAL DISEASE 366
412 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 365
413 HYPERCALCAEMIA 365
414 HEPATOMEGALY 364
415 TOXIC EPIDERMAL NECROLYSIS 364
416 GLIOBLASTOMA 361
417 ESCHERICHIA BACTERAEMIA 359
418 ELECTROCARDIOGRAM QT PROLONGED 358
419 MADAROSIS 358
420 NIGHT SWEATS 358
421 GASTROOESOPHAGEAL REFLUX DISEASE 354
422 SKIN ULCER 354
423 SECONDARY IMMUNODEFICIENCY 353
424 AUTOIMMUNE HAEMOLYTIC ANAEMIA 349
425 MALNUTRITION 349
426 PARAINFLUENZAE VIRUS INFECTION 347
427 ASTHMA 346
428 HISTIOCYTOSIS HAEMATOPHAGIC 346
429 B-CELL LYMPHOMA 344
430 ALTERED STATE OF CONSCIOUSNESS 343
431 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 343
432 NON-HODGKIN^S LYMPHOMA 343
433 BLOOD CULTURE POSITIVE 342
434 RECTAL HAEMORRHAGE 342
435 ENGRAFTMENT SYNDROME 341
436 PLASMA CELL MYELOMA RECURRENT 341
437 DRUG EXPOSURE DURING PREGNANCY 340
438 EMOTIONAL DISTRESS 340
439 RESPIRATORY SYNCYTIAL VIRUS INFECTION 339
440 VASCULITIS 338
441 DRY SKIN 337
442 HEPATOCELLULAR INJURY 336
443 PULMONARY MASS 336
444 PULMONARY ARTERIAL HYPERTENSION 334
445 DYSGEUSIA 333
446 URINARY RETENTION 333
447 HAEMATEMESIS 330
448 SKIN DISORDER 330
449 SKIN INFECTION 330
450 RHABDOMYOLYSIS 327
451 CENTRAL NERVOUS SYSTEM LYMPHOMA 325
452 CONTUSION 325
453 ATAXIA 321
454 ORAL HERPES 321
455 ORAL PAIN 320
456 SQUAMOUS CELL CARCINOMA 320
457 BALANCE DISORDER 319
458 ENTEROCOLITIS 319
459 HAEMATOCHEZIA 317
460 VARICELLA ZOSTER VIRUS INFECTION 317
461 EPSTEIN-BARR VIRAEMIA 316
462 PREMATURE DELIVERY 315
463 HAEMOLYTIC ANAEMIA 314
464 DISCOMFORT 313
465 BLOOD POTASSIUM DECREASED 312
466 GASTROENTERITIS 311
467 GRANULOCYTOPENIA 311
468 NEPHROTIC SYNDROME 311
469 PALLOR 311
470 SUBDURAL HAEMATOMA 311
471 DERMATITIS 310
472 GENERALISED TONIC-CLONIC SEIZURE 309
473 FLUSHING 308
474 HAIR DISORDER 308
475 SMALL INTESTINAL OBSTRUCTION 307
476 FULL BLOOD COUNT DECREASED 306
477 MUSCULOSKELETAL PAIN 306
478 GASTRITIS 305
479 MITRAL VALVE INCOMPETENCE 302
480 WHEEZING 302
481 PNEUMATOSIS INTESTINALIS 299
482 URINARY INCONTINENCE 299
483 SKIN DISCOLOURATION 297
484 PLASMA CELL MYELOMA REFRACTORY 296
485 CIRCULATORY COLLAPSE 295
486 RECURRENT CANCER 295
487 HALLUCINATION 294
488 HYPOGLYCAEMIA 294
489 LEUKAEMIA RECURRENT 294
490 OESOPHAGEAL CANDIDIASIS 293
491 RASH PRURITIC 293
492 VENOUS THROMBOSIS 293
493 CARDIAC DYSFUNCTION 291
494 ADVERSE DRUG REACTION 290
495 IMMUNODEFICIENCY 290
496 NO THERAPEUTIC RESPONSE 290
497 PERITONITIS 290
498 UROSEPSIS 289
499 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 288
500 CAPILLARY LEAK SYNDROME 287
501 DRY MOUTH 287
502 HYPERTRIGLYCERIDAEMIA 287
503 TRANSPLANT REJECTION 287
504 FOETAL GROWTH RESTRICTION 285
505 INFLUENZA LIKE ILLNESS 284
506 STATUS EPILEPTICUS 284
507 CHOLECYSTITIS 283
508 FLUID RETENTION 281
509 FOLLICULAR LYMPHOMA 281
510 HYDROCEPHALUS 281
511 VIRAEMIA 281
512 DISTURBANCE IN ATTENTION 280
513 DIVERTICULITIS 280
514 HAEMORRHOIDS 280
515 HAEMATOMA 279
516 TREATMENT NONCOMPLIANCE 279
517 JOINT SWELLING 278
518 OSTEOMYELITIS 278
519 MASS 277
520 UNEVALUABLE EVENT 277
521 DIPLOPIA 276
522 SQUAMOUS CELL CARCINOMA OF SKIN 276
523 UPPER GASTROINTESTINAL HAEMORRHAGE 275
524 LYMPHOPROLIFERATIVE DISORDER 274
525 NEUTROPHIL COUNT INCREASED 274
526 SWELLING FACE 274
527 MELAENA 273
528 BLOOD UREA INCREASED 272
529 BRAIN ABSCESS 272
530 GUILLAIN-BARRE SYNDROME 271
531 NECK PAIN 271
532 UNRESPONSIVE TO STIMULI 270
533 CONGESTIVE CARDIOMYOPATHY 267
534 MYOSITIS 267
535 CARDIAC FAILURE ACUTE 266
536 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 266
537 ISCHAEMIC STROKE 265
538 POLLAKIURIA 265
539 MALIGNANT MELANOMA 264
540 NEUTROPENIC INFECTION 264
541 VISUAL ACUITY REDUCED 262
542 ABSCESS 261
543 LUNG NEOPLASM MALIGNANT 261
544 MOBILITY DECREASED 261
545 LEUKAEMIA 259
546 PERICARDITIS 258
547 WHITE BLOOD CELL COUNT ABNORMAL 258
548 VENTRICULAR HYPOKINESIA 257
549 ACUTE PULMONARY OEDEMA 256
550 BLOOD SODIUM DECREASED 256
551 ENCEPHALITIS VIRAL 256
552 HYDRONEPHROSIS 256
553 SLEEP DISORDER 256
554 NECROSIS 255
555 NEURALGIA 255
556 PETECHIAE 255
557 ENTEROBACTER INFECTION 254
558 GLIOBLASTOMA MULTIFORME 254
559 RICHTER^S SYNDROME 254
560 CYTOMEGALOVIRUS COLITIS 253
561 GRANULOCYTE COUNT DECREASED 253
562 CYTOMEGALOVIRUS TEST POSITIVE 252
563 HAEMOLYSIS 252
564 DYSPHONIA 251
565 PRODUCT DOSE OMISSION ISSUE 251
566 PROSTATE CANCER 250
567 NEUTROPHIL COUNT ABNORMAL 247
568 OVARIAN FAILURE 246
569 PATHOGEN RESISTANCE 245
570 B-CELL LYMPHOMA RECURRENT 244
571 IMPAIRED HEALING 244
572 HAEMOGLOBIN ABNORMAL 243
573 HOT FLUSH 243
574 LIVER FUNCTION TEST INCREASED 243
575 SYSTEMIC MYCOSIS 243
576 CHOLELITHIASIS 242
577 DRUG ERUPTION 242
578 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 242
579 HAEMODYNAMIC INSTABILITY 242
580 MENINGITIS 242
581 MUSCULOSKELETAL STIFFNESS 242
582 KAPOSI^S SARCOMA 241
583 NOCARDIOSIS 241
584 IMMUNE THROMBOCYTOPENIA 240
585 PERIPHERAL MOTOR NEUROPATHY 238
586 PYELONEPHRITIS 238
587 LACTIC ACIDOSIS 236
588 BLOOD DISORDER 235
589 APPLICATION SITE PAIN 234
590 HEPATIC ENCEPHALOPATHY 234
591 HOSPICE CARE 234
592 NEUROLOGICAL SYMPTOM 233
593 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 232
594 ILEUS PARALYTIC 232
595 THERAPY CESSATION 230
596 TINNITUS 230
597 APPLICATION SITE PRURITUS 229
598 ILLNESS 229
599 THERAPY INTERRUPTED 229
600 VERTIGO 229
601 GENE MUTATION 228
602 TUMOUR PSEUDOPROGRESSION 228
603 ORTHOSTATIC HYPOTENSION 227
604 APPLICATION SITE ERYTHEMA 226
605 ARTHRITIS 225
606 KLEBSIELLA SEPSIS 224
607 ACUTE PROMYELOCYTIC LEUKAEMIA 223
608 ANOREXIA 223
609 BURNING SENSATION 223
610 ENTEROCOCCAL BACTERAEMIA 223
611 LUPUS NEPHRITIS 223
612 MULTIPLE-DRUG RESISTANCE 223
613 CARDIOMEGALY 222
614 GASTROINTESTINAL INFECTION 222
615 RENAL TUBULAR NECROSIS 222
616 BONE MARROW DISORDER 221
617 CYSTITIS VIRAL 221
618 LARGE INTESTINE PERFORATION 221
619 STEVENS-JOHNSON SYNDROME 221
620 TUBERCULOSIS 221
621 BREAST CANCER RECURRENT 220
622 MENTAL DISORDER 220
623 CACHEXIA 219
624 HERPES VIRUS INFECTION 219
625 TOXIC SKIN ERUPTION 219
626 BLOOD CREATINE PHOSPHOKINASE INCREASED 218
627 GASTROINTESTINAL INFLAMMATION 218
628 INFECTION REACTIVATION 218
629 MYOPATHY 218
630 UNDERDOSE 218
631 SUSPECTED OFF LABEL USE 217
632 TOXIC ENCEPHALOPATHY 217
633 TRANSFUSION 217
634 AMNESIA 216
635 ANGINA PECTORIS 216
636 BLOOD ALBUMIN DECREASED 216
637 FLUID OVERLOAD 216
638 DRUG EFFECT INCOMPLETE 215
639 PREMATURE MENOPAUSE 215
640 GASTRIC ULCER 214
641 FUNGAEMIA 213
642 HYPERURICAEMIA 212
643 NASAL CONGESTION 212
644 TROPONIN INCREASED 212
645 ESCHERICHIA URINARY TRACT INFECTION 211
646 IMPAIRED QUALITY OF LIFE 211
647 CANDIDIASIS 210
648 CENTRAL NERVOUS SYSTEM LESION 210
649 LOW BIRTH WEIGHT BABY 210
650 MYELOPATHY 210
651 PRODUCT PRESCRIBING ISSUE 210
652 PLASMACYTOMA 209
653 LUNG CONSOLIDATION 208
654 PAIN IN JAW 208
655 SUDDEN DEATH 208
656 HYPOACUSIS 207
657 OBLITERATIVE BRONCHIOLITIS 207
658 PNEUMONIA KLEBSIELLA 206
659 SHOCK HAEMORRHAGIC 206
660 PNEUMONIA VIRAL 205
661 SUBARACHNOID HAEMORRHAGE 205
662 SERUM FERRITIN INCREASED 204
663 VENTRICULAR TACHYCARDIA 203
664 APPENDICITIS 202
665 TRANSIENT ISCHAEMIC ATTACK 201
666 BLOOD COUNT ABNORMAL 200
667 FACIAL PARALYSIS 200
668 GRAFT VERSUS HOST DISEASE IN LIVER 200
669 HYPERPYREXIA 200
670 SYSTEMIC LUPUS ERYTHEMATOSUS 200
671 RETINAL HAEMORRHAGE 199
672 KLEBSIELLA BACTERAEMIA 198
673 LACRIMATION INCREASED 198
674 RHEUMATOID ARTHRITIS 197
675 STENOTROPHOMONAS INFECTION 197
676 ATRIAL FLUTTER 196
677 SUPRAVENTRICULAR TACHYCARDIA 196
678 BRAIN NEOPLASM 195
679 ENCEPHALITIS CYTOMEGALOVIRUS 195
680 METASTASES TO MENINGES 195
681 PNEUMOCYSTIS JIROVECII INFECTION 195
682 MANTLE CELL LYMPHOMA RECURRENT 194
683 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 194
684 VASCULAR DEVICE INFECTION 194
685 HAEMODIALYSIS 192
686 OBESITY 192
687 STRONGYLOIDIASIS 192
688 HYPERVOLAEMIA 191
689 PNEUMOMEDIASTINUM 191
690 CARDIOVASCULAR DISORDER 190
691 TOXOPLASMOSIS 190
692 INTRACRANIAL PRESSURE INCREASED 189
693 DIFFUSE ALVEOLAR DAMAGE 188
694 CLOSTRIDIAL INFECTION 187
695 POST PROCEDURAL COMPLICATION 187
696 PROCTALGIA 187
697 SOFT TISSUE INFECTION 187
698 ACUTE CORONARY SYNDROME 186
699 MANTLE CELL LYMPHOMA 186
700 OLIGOHYDRAMNIOS 186
701 BONE MARROW TOXICITY 185
702 HEMIPLEGIA 185
703 SENSORY DISTURBANCE 185
704 CHRONIC MYELOID LEUKAEMIA 184
705 CUSHINGOID 184
706 HEPATIC LESION 184
707 PULMONARY CONGESTION 184
708 HEPATOSPLENOMEGALY 183
709 B-CELL TYPE ACUTE LEUKAEMIA 182
710 BONE DISORDER 182
711 CONJUNCTIVITIS 182
712 NEUROLOGICAL DECOMPENSATION 182
713 NON-HODGKIN^S LYMPHOMA RECURRENT 182
714 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 182
715 EXTRAVASATION 181
716 RENAL TUBULAR DISORDER 181
717 CEREBRAL TOXOPLASMOSIS 180
718 INTERNATIONAL NORMALISED RATIO INCREASED 180
719 OLIGURIA 180
720 BRONCHIECTASIS 179
721 DRUG LEVEL INCREASED 179
722 ENDOCARDITIS 179
723 HEPATIC CIRRHOSIS 179
724 LABORATORY TEST ABNORMAL 179
725 OTOTOXICITY 179
726 PLATELET COUNT INCREASED 179
727 PURPURA 179
728 TASTE DISORDER 179
729 HEPATITIS E 178
730 MUSCULOSKELETAL CHEST PAIN 177
731 NODULE 177
732 PHARYNGITIS 177
733 STREPTOCOCCAL BACTERAEMIA 177
734 TRICUSPID VALVE INCOMPETENCE 177
735 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 177
736 ANAPHYLACTIC SHOCK 176
737 ASPERGILLOSIS 176
738 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 176
739 AMENORRHOEA 175
740 ORAL DISORDER 175
741 SKIN HYPERPIGMENTATION 175
742 ARTHROPATHY 174
743 EOSINOPHILIA 174
744 LEFT VENTRICULAR FAILURE 174
745 PRESYNCOPE 174
746 METABOLIC DISORDER 173
747 OBSTRUCTIVE AIRWAYS DISORDER 173
748 STREPTOCOCCAL INFECTION 173
749 APLASIA PURE RED CELL 172
750 OSTEOPENIA 172
751 BONE LESION 171
752 GROWTH RETARDATION 171
753 HEPATITIS C 170
754 HODGKIN^S DISEASE RECURRENT 170
755 ODYNOPHAGIA 170
756 SKIN REACTION 170
757 INCORRECT DOSE ADMINISTERED 169
758 POLYOMAVIRUS VIRAEMIA 169
759 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 168
760 GLOMERULAR FILTRATION RATE DECREASED 168
761 MOVEMENT DISORDER 167
762 OSTEOLYSIS 167
763 RASH PAPULAR 167
764 ULCER 166
765 CARDIAC TAMPONADE 165
766 THROMBOTIC THROMBOCYTOPENIC PURPURA 165
767 MYOCARDIAL ISCHAEMIA 164
768 URINE OUTPUT DECREASED 164
769 CONTRAINDICATED PRODUCT ADMINISTERED 163
770 DEPRESSED MOOD 163
771 DRY EYE 163
772 FEEDING DISORDER 163
773 MEDICATION ERROR 163
774 ANURIA 162
775 TENDERNESS 162
776 VENTRICULAR DYSFUNCTION 162
777 FEELING HOT 160
778 PATHOLOGICAL FRACTURE 160
779 RENAL INJURY 160
780 SKIN NECROSIS 160
781 ACIDOSIS 159
782 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 159
783 ASPIRATION 159
784 BLOOD IMMUNOGLOBULIN G DECREASED 159
785 DIALYSIS 159
786 FAILURE TO THRIVE 159
787 GRAND MAL CONVULSION 159
788 HEPATIC NECROSIS 159
789 BRAIN HERNIATION 158
790 DRUG DOSE OMISSION 158
791 INJECTION SITE PAIN 158
792 PLATELET COUNT ABNORMAL 158
793 EMBOLISM VENOUS 157
794 GLIOMA 157
795 CHRONIC SINUSITIS 156
796 FACE OEDEMA 156
797 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 156
798 DERMATITIS BULLOUS 155
799 INVASIVE DUCTAL BREAST CARCINOMA 155
800 LIPASE INCREASED 155
801 PSEUDOMONAL BACTERAEMIA 155
802 PERFORMANCE STATUS DECREASED 154
803 FLATULENCE 153
804 PARALYSIS 153
805 WOUND INFECTION 153
806 MENINGITIS CRYPTOCOCCAL 152
807 REBOUND EFFECT 152
808 GOUT 151
809 HYPERNATRAEMIA 151
810 ANGIOEDEMA 150
811 ARTHRITIS BACTERIAL 150
812 BLOOD PRESSURE SYSTOLIC INCREASED 150
813 CEREBRAL ISCHAEMIA 150
814 HUMAN POLYOMAVIRUS INFECTION 150
815 HYPERTHERMIA 150
816 METASTASES TO SPINE 150
817 MIGRAINE 150
818 NECROTISING FASCIITIS 150
819 PARTIAL SEIZURES 150
820 PSYCHOTIC DISORDER 150
821 PULMONARY TUBERCULOSIS 150
822 DIABETES INSIPIDUS 149
823 MENINGITIS TUBERCULOUS 149
824 PORTAL HYPERTENSION 149
825 PULMONARY VENO-OCCLUSIVE DISEASE 149
826 BLOOD CALCIUM DECREASED 148
827 ERYSIPELAS 148
828 MOTOR DYSFUNCTION 148
829 STRESS CARDIOMYOPATHY 148
830 ABNORMAL BEHAVIOUR 147
831 DIASTOLIC DYSFUNCTION 147
832 HYPOTONIA 147
833 JUGULAR VEIN THROMBOSIS 147
834 SPINAL PAIN 147
835 TUMOUR HAEMORRHAGE 147
836 DEVICE RELATED SEPSIS 146
837 PAIN OF SKIN 146
838 SKIN BURNING SENSATION 146
839 FEBRILE INFECTION 145
840 THYMUS HYPOPLASIA 144
841 ABDOMINAL PAIN LOWER 143
842 LYMPHOID TISSUE HYPOPLASIA 143
843 METASTATIC MALIGNANT MELANOMA 143
844 RALES 143
845 DIARRHOEA HAEMORRHAGIC 142
846 EYE PAIN 142
847 INTENTIONAL PRODUCT MISUSE 142
848 LYMPHOEDEMA 142
849 ACQUIRED GENE MUTATION 141
850 BONE MARROW TRANSPLANT 141
851 HEPATITIS CHOLESTATIC 141
852 ANGIOPATHY 140
853 EATING DISORDER 140
854 GASTROINTESTINAL PERFORATION 140
855 STRESS 140
856 CORONAVIRUS INFECTION 139
857 DECUBITUS ULCER 139
858 EOSINOPHIL COUNT INCREASED 139
859 FUSARIUM INFECTION 139
860 RESPIRATORY ARREST 139
861 SPINAL FRACTURE 139
862 ERYTHEMA MULTIFORME 138
863 NEPHROLITHIASIS 138
864 RESTLESSNESS 138
865 TYPE 2 DIABETES MELLITUS 138
866 ABDOMINAL ABSCESS 137
867 ABDOMINAL TENDERNESS 137
868 CYANOSIS 137
869 HYPOVOLAEMIA 137
870 INFLAMMATORY MARKER INCREASED 137
871 RIGHT VENTRICULAR FAILURE 137
872 SKIN IRRITATION 137
873 B-LYMPHOCYTE COUNT DECREASED 136
874 CANDIDA SEPSIS 136
875 HYPERMUTATION 136
876 LUNG NEOPLASM 136
877 LYMPHOCYTOSIS 136
878 NAIL DISORDER 136
879 OPPORTUNISTIC INFECTION 136
880 STEROID DIABETES 136
881 VENTRICULAR EXTRASYSTOLES 136
882 EAR PAIN 135
883 GASTROINTESTINAL NECROSIS 135
884 IDIOPATHIC PNEUMONIA SYNDROME 135
885 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 134
886 DYSSTASIA 134
887 LIVER ABSCESS 134
888 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 134
889 MENINGITIS ASEPTIC 134
890 CARDIOPULMONARY FAILURE 133
891 HYPOPROTEINAEMIA 133
892 METASTATIC NEOPLASM 133
893 MYCOBACTERIUM CHELONAE INFECTION 133
894 SARCOIDOSIS 133
895 SKIN MASS 133
896 DYSKINESIA 132
897 FANCONI SYNDROME 132
898 METASTASES TO PERITONEUM 132
899 SUBCLAVIAN VEIN THROMBOSIS 132
900 TRANSPLANT DYSFUNCTION 132
901 FAECES DISCOLOURED 131
902 HYPERTHYROIDISM 131
903 OSTEOARTHRITIS 131
904 SURGERY 131
905 CHOLECYSTITIS ACUTE 130
906 ECZEMA 130
907 RENAL CYST 130
908 VENTRICULAR FIBRILLATION 130
909 COLON CANCER 129
910 DISSEMINATED ASPERGILLOSIS 129
911 ENGRAFT FAILURE 129
912 INJECTION SITE REACTION 129
913 MYOCLONUS 129
914 PAPILLOEDEMA 129
915 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 129
916 RASH GENERALISED 129
917 THROMBOPHLEBITIS 129
918 ANAL ABSCESS 128
919 CYTOGENETIC ABNORMALITY 128
920 GASTRIC HAEMORRHAGE 128
921 SENSORY LOSS 128
922 T-CELL LYMPHOMA 128
923 BRONCHOSPASM 127
924 INJURY 127
925 MULTIPLE MYELOMA 127
926 PARAPLEGIA 127
927 BLOOD LACTIC ACID INCREASED 126
928 CARDIAC FAILURE CHRONIC 126
929 EMPYEMA 126
930 HYPOKINESIA 126
931 RASH MACULAR 126
932 RED BLOOD CELL SEDIMENTATION RATE INCREASED 126
933 TUMOUR NECROSIS 126
934 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 125
935 BLADDER CANCER 125
936 HAEMOLYTIC URAEMIC SYNDROME 125
937 RESPIRATORY RATE INCREASED 125
938 THROAT TIGHTNESS 125
939 CORONARY ARTERY DISEASE 124
940 HEAD INJURY 124
941 LUNG ADENOCARCINOMA 124
942 LUNG OPACITY 124
943 CONGENITAL APLASIA 123
944 DIABETIC KETOACIDOSIS 123
945 ENTEROCOCCAL SEPSIS 123
946 IRRITABILITY 123
947 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 123
948 PNEUMONIA PSEUDOMONAL 123
949 STAPHYLOCOCCUS TEST POSITIVE 123
950 ANAEMIA HAEMOLYTIC AUTOIMMUNE 122
951 FIBROSIS 122
952 HALLUCINATION, VISUAL 122
953 HYPERLIPIDAEMIA 122
954 PARAPARESIS 122
955 TOOTH ABSCESS 122
956 NEUROBLASTOMA 121
957 RED CELL DISTRIBUTION WIDTH INCREASED 121
958 TOOTH INFECTION 121
959 BLOOD MAGNESIUM DECREASED 120
960 BODY TEMPERATURE DECREASED 120
961 PLATELET TRANSFUSION 120
962 THERAPEUTIC PRODUCT EFFECT DECREASED 120
963 DILATED CARDIOMYOPATHY 119
964 HICCUPS 119
965 HYPOFIBRINOGENAEMIA 119
966 IMMUNE SYSTEM DISORDER 119
967 NEPHROPATHY 119
968 PNEUMONIA STAPHYLOCOCCAL 119
969 PROTHROMBIN TIME PROLONGED 119
970 RESPIRATORY SYMPTOM 119
971 VAGINAL HAEMORRHAGE 119
972 VENA CAVA THROMBOSIS 119
973 BURKITT^S LYMPHOMA 118
974 FULL BLOOD COUNT ABNORMAL 118
975 MUSCLE TWITCHING 118
976 CLOSTRIDIUM COLITIS 117
977 GASTROENTERITIS NOROVIRUS 117
978 HUMAN BOCAVIRUS INFECTION 117
979 HYPOVOLAEMIC SHOCK 117
980 MALIGNANT TRANSFORMATION 117
981 PERIPHERAL SENSORIMOTOR NEUROPATHY 117
982 RIB FRACTURE 117
983 ABORTION SPONTANEOUS 116
984 AMYLOIDOSIS 116
985 BLOOD TRIGLYCERIDES INCREASED 116
986 CEREBRAL ASPERGILLOSIS 116
987 HYPOTHERMIA 116
988 INTENTIONAL DOSE OMISSION 116
989 LIMB DISCOMFORT 116
990 LYMPHADENOPATHY MEDIASTINAL 116
991 RENAL CELL CARCINOMA 116
992 SARS-COV-2 TEST POSITIVE 116
993 CLOSTRIDIUM TEST POSITIVE 115
994 DYSAESTHESIA 115
995 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 115
996 ECCHYMOSIS 115
997 FLANK PAIN 115
998 HEPATITIS ACUTE 115
999 MICROANGIOPATHY 115